retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity First-in-Class 'Triple-G'! Retatrutide, a first-in Triple hormone receptor agonist retatrutide

NPJ Metab Health Dis Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression

Research shows that even a 5-10% reduction in body weight can meaningfully lower osteoarthritis symptoms and joint inflammation markers in some individuals

Ascend Research supplies Retatrutide strictly as a laboratory reference material

Front Endocrinol 14(April):123 [Google Scholar] Shah M, Vella A (2014) Effects of GLP-1 on appetite and weight

2007 Jun;56(6):1671-9

GLP-1 receptors (GLP1R), which are found in pancreatic beta cells as well as other cell types, receive the GLP-1 signal, triggering the release of insulin